Videos

Partner for Archbow Consulting discusses the conference, the IRA, and specifics of PAP business rules

Bill Trombetta, PhD, discusses successfully navigating what he calls “the coming perfect storm” in healthcare.

Bayer executive talks Enable Holistic Hub and Provider Services panel.

Founding Partner of Curatio Scientia speaks on her upcoming panel at Trade & Channel Strategies 2023.

Lexicon Pharmaceuticals exec discusses upcoming Enable Holistic Hub and Provider Services panel.

Blue Fin Group exec speaks on his upcoming feature.

Blue Fin Group executive highlights how leaders can plan for immediate profitable lifecycles and beyond.

SVP and Managing Director for Blue Fin Group offers a synopsis of the conference opener.

Director of Berkeley Research Group explains changes to 340B moving forward.

Berkeley Research Group Director discusses what to expect at his upcoming session.

Direct Relief executive provides more information about the company.

Jenifer Smith talks about what to expect during breakout session.

Jenifer Smith provides suggestions on what can be done to continue growth and development.

Direct Relief executive offers her thoughts on breakout session.

Tracy Nasarenko offers her final thoughts on DSCSA implementation guidelines at LogiPharma USA 2023.

Sr. Director of Community Engagement for Pharmaceuticals at GS1 US explains what the implementation guidelines are meant to accomplish.

GS1 US Executive provides insight on how pharma supply can speed up the process of complying with regulations.

In an interview at LogiPharma USA 2023 with Pharma Commerce Editor Nicholas Saraceno, Tracy Nasarenko, Sr. Director of Community Engagement for Pharmaceuticals, GS1 US highlights her “DSCSA—Final Checks to Have Before Deadlines.”

In an interview at the DIA Global Annual Meeting with Pharma Commerce Editor, Nicholas Saraceno, Venkatraman Balasubramanian discusses broader supply chain issues.

In an interview with Pharma Commerce Editor, Nicholas Saraceno, Courtney Granville, Director, Scientific Affairs, Drug Information Association, discusses issues impacting broader supply chains.

In an interview at the DIA Global Annual Meeting with Pharma Commerce Editor, Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses SMART on FHIR and supply chains.

MSD Supply Chain head offers insight on filling roles needed for a digital supply chain.

Head of Supply Chain, EEMEA & APAC for MSD speaks on the challenges to his digital supply chain vision.

MSD executive speaks on his role in supporting a future digital supply chain.

Frederic Brut offers his thoughts on providing a digital supply chain of the future.

VP, Value Chain Management for Johnson & Johnson comments on various problematic supply chain scenarios and how to overcome them.